The economic burden of nephropathy in diabetic patients in Germany in 2002

Diabetes Research and Clinical Practice

Volumn 80, Issue 1, 2008, Pages 34-39

  Happich, M ^a   Landgraf, R ^b   Piehlmeier, W ^b   Falkenstein, Petra ^c   Stamenitis, Sabine ^c  

^a LILLY DEUTSCHLAND GMBH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Kendle GmbH   (Germany)

Author keywords

Burden of disease; Diabetes mellitus; Nephropathy

Indexed keywords

ADULT; AGED; ARTICLE; CASE MANAGEMENT; COST OF ILLNESS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIALYSIS; DISEASE COURSE; FEMALE; GENERAL PRACTITIONER; GERMANY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH RESOURCES; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 40849083851     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.11.012     Document Type: Article

References (19)

1. American Diabetes Association: clinical practice recommendations 2000, Diabetes Care 23 (Suppl. 1) (2000) S1-S116.
2. Koster I., Hauner H., and von Ferber L. Heterogeneity of costs of diabetic patients: the cost of diabetes mellitus study. Dtsch. Med. Wochenschr. 131 15 (2006) 804-810
3. Weber C., Neeser K., Wenzel H., and Schneider B. Costs of diabetes mellitus type 2 and self measurement of blood glucose in Germany. Versicherungsmedizin 58 3 (2006) 133-137
4. Stock S., Redaelli M., Wendland G., Civello D., and Lauterbach K. Diabetes-prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet. Med. 23 3 (2006) 299-305
5. Koster I., von Ferber L., Ihle P., Schubert I., and Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 49 7 (2006) 1498-1504
6. Happich M., Breitscheidel L., Meisinger C., Ulbig M., Falkenstein P., Benter U., et al. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study. Curr. Med. Res. Opin. 23 6 (2007) 1367-1374
7. Happich M., Reitberger U., Breitscheidel L., Ulbig M., and Watkins J. The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch. Clin. Exp. Ophthalmol. (2007)
8. Schwarzeck-Verlag GmbH, The reference medical professional database, http://www.d-medico.de (accessed 2002).
9. Einheitlicher Bewertungsmaßstab (EBM), http://www.gesundheitspolitik.net/02_ambulante-Versorgung/abrechnung/ebm/ebm2002-010101 pdf (accessed 2002).
10. Kassenärztliche Bundesvereinigung. Politisches Aktionsprogramm der Kassenärzte, Available from http://www.kbv.de/gesundheitspolitik/1365 html (accessed 2002).
11. Rote Liste Service GmbH, Red List, Editio Cantor Verlag für Medizin und Naturwissenschaften GmbH 2002.
12. Statistics on retirement 2002, Verband deutscher Versicherungsträger 2002.
13. Liebl A., Neiss A., Spannheimer A., Reitberger U., Wagner T., and Gortz A. Costs of type 2 diabetes in Germany. Results of the CODE-2 study. Dtsch. Med. Wochenschr. 126 20 (2001) 585-589
14. German Diabetes Association. Evidence-Based Guidelines of the German Diabetes Association: Diagnosis, Treatment and Follow-up of Diabetic Nephropathy, 2000, http://www.deutsche-diabetes-gesellschaft.de/redaktion/mitteilungen/leitlinien/EBL_Nephropathie_2000.pdf.
15. Mogensen C. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J. Int. Med. 254 1 (2003) 45-66
16. Rupprecht H., and Piehlmeier W. Recommendations for the management of diabetic patients with nephropathy. MMW Fortschr. Med. 147 21 (2005) 43-46
17. Parving H., Chaturvedi N., Viberti G., and Mogensen C. Does microalbuminuria predict diabetic nephropathy?. Diabetes Care 25 2 (2002) 406-407
18. Tabaei B., Al-Kassab A., Ilag L., Zawacki C., and Herman W. Does microalbuminuria predict diabetic nephropathy?. Diabetes Care 24 9 (2001) 1560-1566
19. Gozzoli V., Palmer A., Brandt A., Weiss C., Piehlmeier W., Landgraf R., et al. Increased clinical and economic advantages using PROSIT (proteinuria screening and intervention) in type 2 diabetic patients. Dtsch. Med. Wochenschr. 125 39 (2000) 1154-1159